Patent · US Active

Modified factor X polypeptides and uses thereof

US9145552B2 · kind B2 · utility

0Cited by

26References

29Claims

0Family size

Assignee

Catalyst Biosciences, Inc. · US

Inventors

Edwin L. Madison · Dallas, US
Christopher D. Thanos · Tiburon, US

Key dates

Filing date	Mar 15, 2013
Grant date	Sep 29, 2015
Priority date	—
Expiry date	Mar 15, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P7/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Modified therapeutic proteins are provided. In particular modified Factor X polypeptides, which includes the Factor X zymogen, Factor Xa and other forms of Factor X, and uses thereof are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.